• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Maplight Therapeutics Reveals 2025 Financials And Business Update

    GLOBENEWSWIRE

    MapLight, Flex Integrate CTMS & eTMF for Streamlined Clinical Ops

    PHARMIWEB

    Novo-Backed Maplight Valued At $787M In Nasdaq Debut

    REUTERS

    Maplight Sustains Biopharma`s Ipo For Alzheimer`s, Schizophrenia

    BIOSPACE

    MapLight Therapeutics Initiates Phase 2 Trial for Alzheimer

    PR NEWSWIRE

    MapLight starts Phase 2 trial of M1/M4 Muscarinic Agonist

    PR NEWSWIRE

    Maplight Report Ph 1 Result for Schizophrenia & Alzheimer’s Disease

    PR NEWSWIRE

    Maplight Announces Completion Of Ph1 Trial For Novel M1/M4 Muscarinic Agonist

    PR NEWSWIRE

    MapLight Therapeutics Closes $225 Million Series C Funding Round

    PR NEWSWIRE

    Exclusive: Trailing Karuna, MapLight Therapeutics aims to improve schizophrenia

    ENDPTS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.